CompletedNot Applicable

CD vs IOD Opposing Mandibular IOD : Bone Height Changes of the Premaxilla

Egypt20 participantsStarted 2022-01-10

Plain-language summary

The goal of this clinical trial is to evaluate bone resorption of the anterior region of maxillary arch. The main questions it aims to answer are: Does implants assisting maxillary complete denture enhance stability, retention and mastication of the patient ? Does implants assisting maxillary complete denture reduce bone resorption in the anterior region of maxilla ? Participants will: * receive 2 implants with attachments assisting their maxillary complete denture * Visit the clinic once every 6 months for checkups and tests

Who can participate

Age range50 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. General good health without any systemic diseases affecting bone resorption such as uncontrolled diabetes or osteoporosis. This was confirmed through taking medical history and clinical examination by a physician.
✓. Having angel's class I maxillo-mandibular relationships.
✓. Presence of sufficient bone quality and quantity in the anterior region of maxilla and mandible which allow inserting implants of at least 3.75 mm diameter and 10 mm length. This was verified by Preoperative low dose Cone Beam (C.T) d) Presence of sufficient restorative space (a minimum of 15 mm must be available from the mucosa covering the crest of the residual ridge to the proposed occlusal plane), this was confirmed by tentative jaw relation.

Exclusion criteria

✕. Uncontrolled systemic diseases such as: uncontrolled hypertension, or uncontrolled cardiovascular disease
✕. metabolic disorders such as diabetes mellitus
✕. Patients with compromised immune systems as (Long term immunosuppressant and corticosteroid drug
✕. TMJ dis orders and neuromuscular diseases
✕. Patient with abnormal habits as clenching and bruxism, Smoking patient, Uncooperative patients.

What they're measuring

bone height changes

Timeframe: 18 months

Trial details

NCT IDNCT06752642

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-15

View on ClinicalTrials.gov More Edentulism trials